share_log

8-K: Current report

SEC ·  Jul 6 04:17
Summary by Futu AI
On July 3, 2024, SeaStar Medical Holding Corporation notified The Nasdaq Stock Market LLC of a possible violation of Nasdaq Listing Rule 5635(d)(2) concerning the issuance of shares without shareholder approval. The issue arose from the conversion of convertible notes and exercise of warrants issued to an institutional investor. These financial instruments were part of a Securities Purchase Agreement from March 15, 2023, which was approved by shareholders at the Annual Meeting on June 28, 2023. Amendments to the agreement on August 7, 2023, and December 11, 2023, involved additional convertible notes and warrants, with adjustments to conversion and exercise prices. SeaStar Medical has requested Nasdaq to review the transactions for compliance and has committed to adhering to Nasdaq's shareholder approval requirements for future securities issuances.
On July 3, 2024, SeaStar Medical Holding Corporation notified The Nasdaq Stock Market LLC of a possible violation of Nasdaq Listing Rule 5635(d)(2) concerning the issuance of shares without shareholder approval. The issue arose from the conversion of convertible notes and exercise of warrants issued to an institutional investor. These financial instruments were part of a Securities Purchase Agreement from March 15, 2023, which was approved by shareholders at the Annual Meeting on June 28, 2023. Amendments to the agreement on August 7, 2023, and December 11, 2023, involved additional convertible notes and warrants, with adjustments to conversion and exercise prices. SeaStar Medical has requested Nasdaq to review the transactions for compliance and has committed to adhering to Nasdaq's shareholder approval requirements for future securities issuances.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.